RBA Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
RBA Wealth Management's GILD Position: Q1 2024 in Review
RBA Wealth Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 4,823 shares — an estimated $391K sold.
RBA Wealth Management first reported a position in GILD in Q1 2019 and held it in 18 quarters. The position peaked at $1.45M in Q1 2019. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- RBA Wealth Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- RBA Wealth Management sold 4,823 Gilead Sciences shares in Q1 2024, an estimated $391K.
- RBA Wealth Management first reported a position in Gilead Sciences in Q1 2019 and held it in 18 quarters.
- RBA Wealth Management's Gilead Sciences position peaked at $1.45M in Q1 2019.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on RBA Wealth Management's 13F filing for Q1 2024, filed 19 Apr 2024.